The Regulation of KSHV Lytic Reactivation by Viral and Cellular Factors

Overview

Journal Curr Opin Virol

Publisher Elsevier

Specialty Microbiology

Date 2021 Dec 6

PMID 34872030

Citations 8

Authors

Praneet Kaur Sandhu

Blossom Damania

Affiliations

Soon will be listed here.

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic herpesvirus that exhibits two distinct phases of infection in the host-latent and lytic. The quiescent latent phase is defined by limited expression of a subset of viral proteins and microRNAs, and an absence of virus production. KSHV periodically reactivates from latency to undergo active lytic replication, leading to production of new infectious virions. This switch from the latent to the lytic phase requires the viral protein regulator of transcription activator (RTA). RTA, along with other virally encoded proteins, is aided by host factors to facilitate this transition. Herein, we highlight the key host proteins that are involved in mediating RTA activation and KSHV lytic replication and discuss the cellular processes in which they function. We will also focus on the modulation of viral reactivation by the innate immune system, and how KSHV influences key immune signaling pathways to aid its own lifecycle.

Citing Articles

Mechanisms underlining R-loop biology and implications for human disease.

Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.

PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.

Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases.

Inagaki T, Espera J, Wang K, Komaki S, Nair S, Davis R bioRxiv. 2025; .

PMID: 40027700 PMC: 11870588. DOI: 10.1101/2025.02.19.639178.

A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.

A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell death.

Miura H, Wang K, Inagaki T, Chuang F, Shimoda M, Izumiya C Cell Chem Biol. 2024; 31(11):1909-1925.e7.

PMID: 39488208 PMC: 11588034. DOI: 10.1016/j.chembiol.2024.10.003.

Ubiquitin-Mediated Effects on Oncogenesis during EBV and KSHV Infection.

Mund R, Whitehurst C Viruses. 2024; 16(10).

PMID: 39459858 PMC: 11512223. DOI: 10.3390/v16101523.

References

Ma Z, Hopcraft S, Yang F, Petrucelli A, Guo H, Ting J . NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency. PLoS Pathog. 2017; 13(5):e1006350. PMC: 5426799. DOI: 10.1371/journal.ppat.1006350. View

Zhao Y, Ye X, Shehata M, Dunker W, Xie Z, Karijolich J . The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV. Nat Commun. 2020; 11(1):3345. PMC: 7334219. DOI: 10.1038/s41467-020-17151-2. View

Gu F, Wang C, Wei F, Wang Y, Zhu Q, Ding L . STAT6 degradation and ubiquitylated TRIML2 are essential for activation of human oncogenic herpesvirus. PLoS Pathog. 2018; 14(12):e1007416. PMC: 6287816. DOI: 10.1371/journal.ppat.1007416. View

Li J, Zhao J, Xu S, Zhang S, Zhang J, Xiao J . Antiviral activity of a purine synthesis enzyme reveals a key role of deamidation in regulating protein nuclear import. Sci Adv. 2019; 5(10):eaaw7373. PMC: 6785261. DOI: 10.1126/sciadv.aaw7373. View

Dillon P, Gregory S, Tamburro K, Sanders M, Johnson G, Raab-Traub N . Tousled-like kinases modulate reactivation of gammaherpesviruses from latency. Cell Host Microbe. 2013; 13(2):204-14. PMC: 3602413. DOI: 10.1016/j.chom.2012.12.005. View

Li D, Swaminathan S . Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS Pathog. 2019; 15(2):e1007609. PMC: 6396945. DOI: 10.1371/journal.ppat.1007609. View

Cai Q, Lan K, Verma S, Si H, Lin D, Robertson E . Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions. J Virol. 2006; 80(16):7965-75. PMC: 1563785. DOI: 10.1128/JVI.00689-06. View

Jacobs S, Stopford C, West J, Bennett C, Giffin L, Damania B . Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway. J Virol. 2015; 89(22):11572-83. PMC: 4645652. DOI: 10.1128/JVI.01482-15. View

Dalton-Griffin L, Wilson S, Kellam P . X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J Virol. 2009; 83(14):7202-9. PMC: 2704782. DOI: 10.1128/JVI.00076-09. View

10.

Jackson B, Noerenberg M, Whitehouse A . A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells. PLoS Pathog. 2014; 10(5):e1004098. PMC: 4006916. DOI: 10.1371/journal.ppat.1004098. View

11.

Ballestas M, Chatis P, Kaye K . Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999; 284(5414):641-4. DOI: 10.1126/science.284.5414.641. View

12.

Li Q, He M, Zhou F, Ye F, Gao S . Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle. J Virol. 2014; 88(11):6355-67. PMC: 4093851. DOI: 10.1128/JVI.00219-14. View

13.

Gwack Y, Nakamura H, Lee S, Souvlis J, Yustein J, Gygi S . Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol Cell Biol. 2003; 23(22):8282-94. PMC: 262387. DOI: 10.1128/MCB.23.22.8282-8294.2003. View

14.

Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman P . Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol. 2003; 77(21):11425-35. PMC: 229253. DOI: 10.1128/jvi.77.21.11425-11435.2003. View

15.

Liang Y, Ganem D . Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc Natl Acad Sci U S A. 2003; 100(14):8490-5. PMC: 166256. DOI: 10.1073/pnas.1432843100. View

16.

Gao R, Li T, Tan B, Ramos da Silva S, Jung J, Feng P . FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency. J Virol. 2018; 93(3). PMC: 6340022. DOI: 10.1128/JVI.01681-18. View

17.

Hollingworth R, Horniblow R, Forrest C, Stewart G, Grand R . Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. J Virol. 2017; 91(22). PMC: 5660498. DOI: 10.1128/JVI.00930-17. View

18.

Hesser C, Karijolich J, Dominissini D, He C, Glaunsinger B . N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog. 2018; 14(4):e1006995. PMC: 5919695. DOI: 10.1371/journal.ppat.1006995. View

19.

West J, Damania B . Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol. 2008; 82(11):5440-9. PMC: 2395190. DOI: 10.1128/JVI.02590-07. View

20.

Gregory S, West J, Dillon P, Hilscher C, Dittmer D, Damania B . Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A. 2009; 106(28):11725-30. PMC: 2710638. DOI: 10.1073/pnas.0905316106. View